Stay Connected - Sign up for Updates

Connecting Investors and Business Leaders to Accelerate Cancer Innovation

Join us for an exclusive gathering of senior-level investors, corporate executives, entrepreneurs, and business leaders at Oncology Venture, Innovation & Partnering Summit. Connect with future investors and partners at intimate networking sessions; gain strategic insights on funding activities, exits, business development, and innovation strategies in cancer therapeutics and diagnostics from industry-led panels; and hear candid perspectives and business recommendations from oncology thought leaders during dynamic fireside chats.

Building on the 30+ year history of producing cutting-edge meetings on all aspects of cancer drug and diagnostic development, Cambridge Innovation Institute is pleased to announce the leading meeting dedicated to oncology business development, funding and partnering. Oncology Venture, Innovation & Partnering Summit takes place October 9-10, 2024, in Cambridge, MA. Part of CII’s new Cambridge VIP division, the Oncology VIP Summit brings together senior-level investors, corporate executives, entrepreneurs, and start-up leaders working on oncology innovation. This high-level, networking event consists of thought-provoking, industry-led panels, fireside chats, and numerous networking opportunities for start-ups, investors, and potential acquirers to foster meaningful connections. You are invited to join us at this conference to acquire valuable strategic insights, honest perspectives, and practical business recommendations for collaboration, investment, and company strategy.

Event features:

  • Network with investors, CEOs, and pharma business leaders at exclusive receptions and networking events
  • Gather actionable insights from oncology business leaders during engaging panel discussions
  • Strategize for commercial success and learn from oncology executives at fireside chats
  • Brainstorm most timely topics and meet future partners and investors at targeted roundtables
  • Join the annual meeting and accelerate cancer innovation!

Cambridge VIP Attendee Demographics

VIP Demographics

2024 Agenda Topics Include

  • Future opportunities in oncology investments and strategies to de-risk
  • Emerging oncology therapeutics and modalities: radiopharmaceuticals, antibody-drug conjugates, CAR T-cell therapy, etc.
  • Policy implications affecting oncology investors and operators: Inflation Reduction Act, BIOSECURE Act, and an upcoming election
  • Cancer diagnostics, screening, and early detection
  • Where does Artificial Intelligence add value in oncology: from discovery to care delivery?
  • Big pharma perspective on oncology venture, partnering, and M&A
  • Is “precision medicine” working?
  • Innovation in oncology clinical trials
  • Improving oncology care delivery and health equity
  • Ups and downs of immuno-oncology
  • How to deliver value-based care in oncology?

Cambridge VIP Events Testimonials

1 on 1 Networking
Keynote Talks
Panel Discussions
Networking and Reception

Who Should Attend


  • VC/PE/CVC Investors & Angels
  • Senior Investors (Managing Partners/Directors & General Partners)
  • Investors (Partners, Investors & Principals)
  • Portfolio Advisors (Venture & Operating Partners)


  • Emerging Company Leaders
  • Founders & CEOs
  • C-Suite Executives (CSOs, CIOs, CTOs, etc.)
  • Innovation & Strategy Managers (SVPs, VPs & Directors)


  • Pharmaceutical, Diagnostic, and Device Company Executives
  • Business Development Heads (SVPs, VPs & Directors)
  • Innovation & Strategy Managers (SVPs, VPs & Directors)
  • Venture Leaders (Managing Directors, Partners & Directors)

Key Contacts:

Benjamin Lakin, PhD


Benjamin Lakin, PhD
Co-Chief Executive Officer
(+1) 781.972.5454

Julia Boguslavsky


Julia Boguslavsky
Executive Director, Conferences

Brian Caine


Brian Caine
Business Development Manager, Investor Series
(+1) 908.809.0946